TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-2

D Kaushik, R Bhandari, A Kuhad - Expert Opinion on Therapeutic …, 2021 - Taylor & Francis
Introduction: The COVID-19 pandemic remains aglobal challenge. While there are mRNA
agents on the horizon as apotential prevention, adefinitive drug therapy is an unmet medical …
被引用次数：42 相关文章
[PDF] academia.edu

[PDF][PDF] TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-2

D Kaushik, R Bhandari, A Kuhad - EXPERT OPINION ON …, 2021 - academia.edu
Introduction: The COVID-19 pandemic remains aglobal challenge. While there are mRNA
agents on the horizon as apotential prevention, adefinitive drug therapy is an unmet medical …

TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-2.

D Kaushik, R Bhandari, A Kuhad - Expert Opinion on Therapeutic …, 2021 - europepmc.org
Introduction: The COVID-19 pandemic remains aglobal challenge. While there are mRNA
agents on the horizon as apotential prevention, adefinitive drug therapy is an unmet medical …

TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-2

D Kaushik, R Bhandari… - Expert opinion on …, 2021 - pubmed.ncbi.nlm.nih.gov
Introduction: The COVID-19 pandemic remains aglobal challenge. While there are mRNA
agents on the horizon as apotential prevention, adefinitive drug therapy is an unmet medical …
[HTML] nih.gov

[HTML][HTML] TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-2

D Kaushik, R Bhandari, A Kuhad - Expert Opinion on Therapeutic …, 2021 - ncbi.nlm.nih.gov
Introduction: The COVID-19 pandemic remains aglobal challenge. While there are mRNA
agents on the horizon as apotential prevention, adefinitive drug therapy is an unmet medical …